The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $522,000 in first-year total cost, median $261,000.
Most frequent study sections
- Enabling Bioanalytical and Imaging Technologies Study Section[EBIT]1
- Pathobiology of Kidney Disease Study Section[PBKD]1
Most frequent institutions
- BETH ISRAEL DEACONESS MEDICAL CENTER1
- MASSACHUSETTS GENERAL HOSPITAL1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | Retinoid mediated protection against AKI during aging1R21AG047412-01A1 | KOTA, SAVITHRI BALASUBRAMANIAN | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $261,000 | PBKD |
| 2015 | Transient Obstruction of Capillary Networks by Chromatin Yarns from Neutrophils in Older Adults1R21AG051082-01 | IRIMIA, DANIEL | MASSACHUSETTS GENERAL HOSPITAL, MA | $261,000 | EBIT |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.